Video from AACC: Siemens Healthineers’ NAFLD test

2022 07 28 21 06 4536 Charles Cooper 400

Siemens Healthineers CMO Charles Cooper spoke to us about the firm’s Enhanced Liver Fibrosis blood test and how it can be used to assess the risk of nonalcoholic fatty liver disease (NAFLD) progression and liver-related events.

Click on the video below for the interview.

Siemens Healthineers CMO Charles Cooper.

Page 1 of 3
Next Page